621 results on '"Bielle, Franck"'
Search Results
2. Base-excision repair pathway shapes 5-methylcytosine deamination signatures in pan-cancer genomes
3. Correlation between natural history and multi-omics profiling of meningiomas in NF2-related schwannomatosis suggests role of methylation group and immune microenvironment in tumor growth rate
4. Microsatellite instability at U2AF-binding polypyrimidic tract sites perturbs alternative splicing during colorectal cancer initiation
5. CNS tumors with PLAGL1-fusion: beyond ZFTA and YAP1 in the genetic spectrum of supratentorial ependymomas
6. Lynch syndrome: influence of additional susceptibility variants on cancer risk
7. Comparative microanatomy and histology of spinal and cerebral veins: Implications for dural arteriovenous fistula clinical presentations
8. Cellular senescence in malignant cells promotes tumor progression in mouse and patient Glioblastoma
9. Respective roles of Pik3ca mutations and cyproterone acetate impregnation in mouse meningioma tumorigenesis
10. Comparative analysis of deeply phenotyped GBM cohorts of ‘short-term’ and ‘long-term’ survivors
11. REVOLUMAB: A phase II trial of nivolumab in recurrent IDH mutant high-grade gliomas
12. Integrated proteogenomic characterization of glioblastoma evolution
13. Cell of Origin of Brain and Spinal Cord Tumors
14. An AI-powered blood test to detect cancer using nanoDSF
15. Integrative multi-omics networks identify PKCδ and DNA-PK as master kinases of glioblastoma subtypes and guide targeted cancer therapy
16. Roles and outcomes of stereotactic biopsy for adult patients with brainstem lesion
17. Single-Cell Transcriptomic Analyses of Brain Parenchyma in Patients With New-Onset Refractory Status Epilepticus (NORSE)
18. Epstein-Barr Virus and immune status imprint the immunogenomics of non-Hodgkin lymphomas occurring in immune-suppressed environments
19. Epilepsy related to focal neuronal lipofuscinosis: extra-frontal localization, EEG signatures and GABA involvement
20. Glioblastoma Stem Cells
21. Pan-cancer landscape of AID-related mutations, composite mutations, and their potential role in the ICI response
22. SARS-CoV-2 infection in patients with primary central nervous system lymphoma
23. Mismatch Repair Deficiency and Lynch Syndrome Among Adult Patients With Glioma
24. Neuropathology of the temporal lobe
25. WHO 2021 and beyond: new types, molecular markers and tools for brain tumor classification
26. Clinical characteristics and long-term surgical outcome of spinal myxopapillary ependymoma: a French cohort of 101 patients
27. Identification of a putative molecular subtype of adult-type diffuse astrocytoma with recurrent MAPK pathway alterations.
28. Neuropathologie de l’épilepsie
29. Neurological diseases of unknown etiology: Brain-biopsy diagnostic yields and safety
30. Pathway-based classification of glioblastoma uncovers a mitochondrial subtype with therapeutic vulnerabilities
31. BRAIN METASTASIS OF A UROTHELIAL NEUROENDOCRINE CARCINOMA: A DOUBLE PITFALL FOR NEUROPATHOLOGISTS AND DNA‐METHYLATION PROFILING
32. Mechanisms and therapeutic implications of hypermutation in gliomas
33. Rheumatoid meningitis sine arthritis: An emerging cause of isolated pachymeningitis and leptomeningitis with typical features
34. Increasing the diagnostic yield of stereotactic brain biopsy using intraoperative histological smear
35. Ultrasound-Induced Blood–Spinal Cord Barrier Opening in Rabbits
36. Treatment of grade II–III intracranial meningioma with helical tomotherapy
37. Transcriptional CDK inhibitors, CYC065 and THZ1 promote Bim-dependent apoptosis in primary and recurrent GBM through cell cycle arrest and Mcl-1 downregulation
38. CSIG-30. FUNCTIONAL CHARACTERISATION OF A NOVEL MUTATION IN PRKCA, THE MAJOR DRIVER OF CHORDOID GLIOMAS
39. CTNI-33. TARGET TRIAL: A PHASE I/II OPEN-LABEL MULTICENTER STUDY TO ASSESS SAFETY, TOLERABILITY, AND CLINICAL EFFICACY OF AZD4547 IN PATIENTS WITH RELAPSED/REFRACTORY FGFR FUSION POSITIVE GLIOMA
40. DDDR-09. FUNCTIONAL GENOMICS AND CHEMOTHERAPY RESISTANCE SCREENING IDENTIFIES BIOMARKERS AND TARGETABLE MECHANISMS OF CCNU RESISTANCE IN GLIOMAS
41. EXTH-59. IDENTIFICATION OF GROWTH HORMONE RECEPTOR AS A RELEVANT TARGET FOR PRECISION MEDICINE IN LOW-EGFR EXPRESSING GLIOBLASTOMA
42. EPCO-37. DISSECTING GBM EVOLUTION FOLLOWING STANDARD-OF-CARE BY LARGE-SCALE LONGITUDINAL SINGLE NUCLEUS RNA-SEQUENCING
43. EPCO-09. CHARACTERIZING THE GBM CELLULAR LANDSCAPE BY LARGE-SCALE SINGLE-NUCLEUS RNA-SEQUENCING
44. Exploring the mechanism of 18F‐fluorodopa uptake in recurrent high‐grade gliomas: A comprehensive histomolecular‐positron emission tomography analysis
45. Hippocampal and neocortical BRAF mutant non‐expansive lesions in focal epilepsies
46. Enhancing KCC2 function reduces interictal activity and prevents seizures in mesial temporal lobe epilepsy
47. Neurochemical Differences between 1p/19q Codeleted and Noncodeleted IDH-mutant Gliomas by in Vivo MR Spectroscopy
48. Neuronal migration of guidepost cells
49. Contributors
50. Bioactive glass granules for mastoid and epitympanic surgical obliteration: CT and MRI appearance
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.